INLYTA - 0069-0145-01 - (AXITINIB)

Alphabetical Index


Drug Information of INLYTA

Product NDC: 0069-0145
Proprietary Name: INLYTA
Non Proprietary Name: AXITINIB
Active Ingredient(s): 1    mg/1 & nbsp;   AXITINIB
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of INLYTA

Product NDC: 0069-0145
Labeler Name: Pfizer Laboratories Div Pfizer Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA202324
Marketing Category: NDA
Start Marketing Date: 20120127

Package Information of INLYTA

Package NDC: 0069-0145-01
Package Description: 180 TABLET, FILM COATED in 1 BOTTLE (0069-0145-01)

NDC Information of INLYTA

NDC Code 0069-0145-01
Proprietary Name INLYTA
Package Description 180 TABLET, FILM COATED in 1 BOTTLE (0069-0145-01)
Product NDC 0069-0145
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name AXITINIB
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20120127
Marketing Category Name NDA
Labeler Name Pfizer Laboratories Div Pfizer Inc
Substance Name AXITINIB
Strength Number 1
Strength Unit mg/1
Pharmaceutical Classes Kinase Inhibitor [EPC],Receptor Tyrosine Kinase Inhibitors [MoA]

Complete Information of INLYTA


General Information